X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (20) 20
hematology (17) 17
humans (14) 14
hemophilia (9) 9
male (9) 9
pediatrics (9) 9
female (8) 8
oncology (8) 8
child (7) 7
children (6) 6
thrombin generation (6) 6
adolescent (5) 5
inhibitors (5) 5
management (5) 5
peripheral vascular disease (5) 5
care and treatment (4) 4
hemostasis (4) 4
medical research (4) 4
patients (4) 4
thrombosis (4) 4
adult (3) 3
antibodies (3) 3
bleeding (3) 3
blood coagulation factor viii (3) 3
child, preschool (3) 3
factor-viii (3) 3
glanzmann thrombasthenia (3) 3
health aspects (3) 3
infant, newborn (3) 3
infants (3) 3
medicine, experimental (3) 3
neonates (3) 3
outcomes (3) 3
pregnancy (3) 3
recombinant (3) 3
registry treatment (3) 3
retrospective studies (3) 3
rfviia (3) 3
thrombin (3) 3
activated factor-vii (2) 2
acupuncture therapy (2) 2
alpha-iib-beta-3 (2) 2
bispecific antibody (2) 2
bleeding disorders (2) 2
blood coagulation factors - therapeutic use (2) 2
bypassing agent therapy (2) 2
clinical trials (2) 2
coagulation factors (2) 2
disease (2) 2
emicizumab (2) 2
experience (2) 2
factor viii (2) 2
factor viii - immunology (2) 2
factor viii - therapeutic use (2) 2
feiba (2) 2
fetuses (2) 2
follow-up studies (2) 2
guidelines (2) 2
hemophilia a (2) 2
hemophilia a - diagnosis (2) 2
hemophilia a - epidemiology (2) 2
hemophilia a - immunology (2) 2
hemophilia a - therapy (2) 2
hemophilia b (2) 2
hemorrhage - blood (2) 2
immune tolerance (2) 2
infant (2) 2
intracranial hemorrhage (2) 2
medical colleges (2) 2
molecular-weight heparin (2) 2
mucormycosis (2) 2
mutation (2) 2
pediatric (2) 2
platelets (2) 2
prognosis (2) 2
prothrombotic risk-factors (2) 2
review article (2) 2
risk factors (2) 2
rotem (2) 2
surgery (2) 2
therapy (2) 2
thrombin generation assay (2) 2
thrombocytopenia (2) 2
thromboembolism (2) 2
thrombophilia (2) 2
treatment outcome (2) 2
a patients (1) 1
absence seizures (1) 1
acquired hemophilia a (1) 1
active cancer (1) 1
acupuncture (1) 1
acute disease (1) 1
acute invasive fungal rhinosinusitis (1) 1
acute lymphoblastic-leukemia (1) 1
acute-phase proteins - analysis (1) 1
adolescence (1) 1
adolescents (1) 1
all (1) 1
allergic reactions (1) 1
allergy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Harefuah, ISSN 0017-7768, 03/2019, Volume 158, Issue 3, p. 187
Deep Venous Thrombosis (DVT) is rare among children, yet may yield high morbidity and mortality. Due to the limited data regarding pediatric DVT, its... 
Thrombophilia | Humans | Risk Factors | Venous Thrombosis | Retrospective Studies | Venous Thromboembolism - epidemiology | Child | Venous Thromboembolism - therapy | Cohort Studies | Venous Thromboembolism - diagnosis
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 10/2018, Volume 65, Issue 10, pp. e27281 - n/a
Background Invasive mold infections (IMIs) are a leading cause of mortality among immunocompromised patients. Isavuconazole is a new drug that shows promise in... 
isavuconazole | immunocompromised | mucormycosis | pediatric | RISK-FACTORS | ONCOLOGY | GUIDELINES | DISEASE | MOLD INFECTIONS | PEDIATRICS | HEMATOLOGY | CHILDREN | Mucormycosis | Pediatrics | Care and treatment | Children | Health aspects | Mortality | Adolescence | Medical research | Demographics | Demography | Clinical trials | Pharmacology | Immunocompromised hosts | Adolescents | Patients
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 11/2019, Volume 66, Issue 11, pp. e27886 - n/a
Background Emicizumab is a bispecific antibody that bridges factor IXa and factor X to restore hemostasis in patients with hemophilia A (HA). Its efficacy and... 
emicizumab | hemophilia A | inhibitors | thrombin generation | ROTEM | MANAGEMENT | FACTOR-VIII | BISPECIFIC ANTIBODY | THERAPY | ONCOLOGY | PEDIATRICS | OUTCOMES | HEMATOLOGY | Therapy | Parameters | Prophylaxis | Clinical trials | Antibodies | Thrombin | Infants | Trauma | Patients | Bleeding | Coagulation factors | Inhibitors | Hemostasis | Hemophilia | Hemostatics | Children | Safety | Bispecific antibodies | Recombinant
Journal Article
Seminars in Thrombosis and Hemostasis, ISSN 0094-6176, 09/2018, Volume 44, Issue 6, pp. 544 - 550
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 01/2019, Volume 119, Issue 1, pp. 117 - 127
Abstract Introduction  Glanzmann thrombasthenia (GT) is a rare bleeding disorder. The disease is caused by the lack or dysfunction of platelet membrane... 
Cellular Haemostasis and Platelets | rFVIIa | thrombin generation | Glanzmann thrombasthenia | MICROPARTICLE FORMATION | GENETIC-BASIS | DEFICIENT PATIENTS | REGISTRY TREATMENT | ACTIVATED FACTOR-VII | BLEEDING EPISODES | PLATELETS | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | GLYCOPROTEIN-IIB-IIIA | IRAQI-JEWISH
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2397 - 2397
Background: Hemlibra is a bispecific antibody that bridges factor IXa and factor X to restore hemostasis in patients with Hemophilia A (HA). It has proven... 
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 12/2018, Volume 65, Issue 12, pp. e27381 - n/a
Little is known about the challenging treatment of pediatric patients with hemophilia B and inhibitors due to disease rarity. We describe three patients... 
FEIBA | inhibitor | rFVIIa | thrombin generation | hemophilia B | THERAPY | ONCOLOGY | PEDIATRICS | FUTURE | HEMATOLOGY | Thrombin | Hemophilia B | Care and treatment | Analysis | Prothrombin complex concentrate | Hemophilia | Pediatrics | Coagulation factor VIIa | Hypersensitivity | Allergic reactions | Thrombosis | Patients | Bleeding | Coagulation factors | Inhibitors | Surgery | Prothrombin | Children | Thromboembolism | Recombinant
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4191 - 4191
Background: Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm. As it is extremely rare in children, data regarding its clinical course... 
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 06/2016, Volume 63, Issue 6, pp. 1120 - 1122
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 08/2017, Volume 64, Issue 8, p. e26447
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3964 - 3964
Abstract Mucormycosis has emerged as an increasingly important infection in patients with hematological malignancies, and is associated with considerable... 
Journal Article
Blood Cells, Molecules and Diseases, ISSN 1079-9796, 02/2020, Volume 80, p. 102370
Hemophilia is a rare bleeding disorder caused by a deficiency of the plasma coagulation factors VIII and IX (hemophilia A [HA] and hemophilia B [HB],... 
Thrombin generation | Allergy | Hemophilia B | Anaphylaxis | Hemophilia A | BLEEDING DISORDERS | DESENSITIZATION | FACTOR-VIII | EMICIZUMAB | ANAPHYLACTIC REACTION | RITUXIMAB | FACTOR-IX | ANTITHROMBIN | PATIENT | IMMUNE TOLERANCE | HEMATOLOGY
Journal Article
Harefuah, ISSN 0017-7768, 03/2019, Volume 158, Issue 3, p. 173
Hemophilia is a hereditary congenital hemorrhagic diathesis caused by mutations in blood coagulation factor VIII (FVIII) or IX (FIX) genes, causing hemophilia... 
Israel - epidemiology | Europe | Humans | Factor VIII | Male | Hemophilia A - epidemiology | Retrospective Studies | Hemophilia A - diagnosis | Child | Infant, Newborn
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.